Pregnancy is associated with changes in insulin sensitivity which may lead to changes in plasma glucose levels. For women with known diabetes or for women who develop diabetes during the pregnancy, these changes can put outcomes at risk. This guideline deals with the means of identifying women for whom such problems are new, and helping them, as well as women already known to have diabetes, to achieve the desired outcome of a healthy mother and baby.
Within the IDF Global Guideline for Type 2 Diabetes of 2005 there was a section on pregnancy, but this did not address type 1 diabetes and did not consider the wider issues surrounding gestational diabetes mellitus (GDM). The current guideline includes these additional topics, and attempts to present some of the evidence bearing on areas of controversy.